Optimi Health Completes First Export of MDMA Capsules to Australia for the Treatment of PTSD Page 1

Vancouver, British Columbia–(Newsfile Corp. – August 16, 2024) – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) (“Optimistic” or the “Company“), a GMP-approved, Health Canada licensed pharmaceutical psychedelic manufacturer specializing in plant-based psilocybin and MDMA, is pleased to announce that it has completed the first export of its GMP-validated MDMA capsules to Australia for the treatment of PTSD, along with a series of notable developments within the company.

Export of MDMA capsules to Australia